Statement Of Changes In Equity [Abstract]

Zealand Pharma - Filing #1382971

Concept As at
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
2022-01-01 to
2022-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
As at
2021-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
2020-01-01 to
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
As at
2020-12-31
2020-01-01 to
2020-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-12-31
Statement of changes in equity [abstract]
Statement of changes in equity [line items]
Equity
815,911,000 EUR
749,592,000 EUR
51,702,000 EUR
14,617,000 EUR
870,014,000 EUR
927,803,000 EUR
14,155,000 EUR
43,634,000 EUR
39,800,000 EUR
8,977,000 EUR
1,180,534,000 EUR
1,229,311,000 EUR
1,206,618,000 EUR
0 EUR
1,242,673,000 EUR
36,055,000 EUR
Changes in equity [abstract]
Comprehensive income [abstract]
Profit (loss)
0 EUR
1,202,135,000 EUR
1,202,135,000 EUR
0 EUR
1,018,149,000 EUR
0 EUR
0 EUR
1,018,149,000 EUR
846,729,000 EUR
846,729,000 EUR
0 EUR
0 EUR
Other comprehensive income
0 EUR
0 EUR
462,000 EUR
462,000 EUR
0 EUR
5,178,000 EUR
0 EUR
5,178,000 EUR
8,977,000 EUR
0 EUR
0 EUR
8,977,000 EUR
Comprehensive income
1,201,673,000 EUR
1,012,971,000 EUR
837,752,000 EUR
Issue of equity
8,068,000 EUR
1,076,593,000 EUR
1,084,661,000 EUR
0 EUR
771,211,000 EUR
0 EUR
3,834,000 EUR
775,045,000 EUR
836,611,000 EUR
832,866,000 EUR
3,745,000 EUR
0 EUR
Increase (decrease) through treasury share transactions, equity
70,190,000 EUR
0 EUR
0 EUR
70,190,000 EUR
Increase (decrease) through share-based payment transactions, equity
0 EUR
52,576,000 EUR
52,576,000 EUR
0 EUR
53,504,000 EUR
0 EUR
0 EUR
53,504,000 EUR
30,485,000 EUR
30,485,000 EUR
0 EUR
0 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.